According to Piramal Pharma's latest financial reports the company has $80.12 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $89.48 M | 78.85% |
2022-03-31 | $50.03 M | 126.32% |
2021-03-31 | $22.1 M |